Ilian Iliev is the chief executive of NetScientific, an AIM-listed investor that specialises in helping its medtech, therapeutics, sustainability and robotics portfolio grow in Asia, Europe and the US.
Iliev, who came to NetScientific after the company acquired his VC firm EMV Capital (he remains managing director of the subsidiary), also tells us how that merger came to be, how the combined group isn’t afraid of acquiring startups to help turn them around before seeking external funding once more, and why the financial regulations around being a publicly traded company are a positive.
He also ponders how living through the fall of communism and South African apartheid has shaped his views, and how his education at Cambridge convinced him that investing in a local fund, Martlet Capital, made sense.
Subscribe
 |
 |
 |
 |
 |
 |
 |
 |
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
